Semaglutide (Ozempic) and its siblings the GLP-1 agonists have made it into the public consciousness in a big way. With many celebrities showing off significant weight loss and better bodies, ...

Still life of Wegovy an injectable prescription weight loss medicine that has helped people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael ...

Among the most recently approved drugs for weight management, glucagon-like peptide 1 (GLP-1) agonists have garnered considerable attention; however, the effects of these drugs on the gastrointestinal ...

Taking drugs like Ozempic for weight loss may come with a slight risk of severe gastrointestinal (GI) problems, including inflammation of the pancreas and too-slow stomach movements, sometimes called ...

Semaglutide, tirzepatide, and dulaglutide have similar gastrointestinal safety profiles among patients with type 2 diabetes (T2D), an active-comparator cohort study showed. “We were somewhat surprised ...

Scientists headed by a team at the University of British Columbia (UBC) have developed a new approach to drug design that can deliver therapeutics directly to a specific part of the gastrointestinal ...

A deep dive into public Facebook posts uncovers the real-world side effect patterns of GLP-1 medications, revealing what users actually experience outside of clinical trials. Study: Harnessing ...

Three popular GLP-1 receptor agonists carried similar risks for serious gastrointestinal (GI) events among adults with type 2 diabetes, although all higher than seen with sodium-glucose cotransporter ...